in this issue
People & Business :: Earnings/Finance
Bayer maintains its growth momentum
10:03 AM MST | March 1, 2013
Bayer says it achieved its targets for 2012. Speaking at a media briefing in Leverkusen on 28 February, Marijn Dekkers, CEO, said that all of Bayer’s subgroups—Bayer HealthCare, Bayer CropScience, and Bayer MaterialScience—“posted gains in sales and earnings before special items.” The life-science businesses, comprising HealthCare and CropScience, registered particularly rapid growth and were strengthened by further progress in their innovation pipelines. The company expects “to continue our record development in 2013 and...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee